Asian Urology Residents’ Course
John D. Denstedt, MD, FRCSC, FACS, FCAHS
Dr. John Denstedt graduated from medical school in 1982 at The University of Western Ontario inLondon, Canada. He completed his residency in Urology at Western between 1983 and 1987followed by a fellowship in Endourology at Washington University in St. Louis. He returned toLondon and joined the Division of Urology in the Department of Surgery at Western in 1990.
In July 2002 he assumed the role of City - Wide Chair and Chief of the Department of Surgery at Western University and served in this role for 14 years. Dr. Denstedt is a Past Chair of the Canadian Association of Surgical Chairs and a past member of the American Urological Association Board of Directors. He completed a 10 year term as Treasurer of the Endourological Society in 2018.
While maintaining an active clinical practice, Dr. Denstedt is an internationally renowned scholar in urology with
career accomplishments encompassing over 250 published papers and book chapters, more than 400 guest professorships in countries throughout the world and numerous honours and awards including being the ﬁrst Canadian to have won the Gold Cystoscope Award from the American Urological Association in 1998. In 2019 he was awarded the Karl Storz Lifetime Achievement Award from the Endourological Society. Dr. Denstedt has served on the Editorial Board of eight major journals in Urology and is the immediate past Executive Editor of the Journal of Endourology. He is currently the Secretary of the American Urological Association the world’s largest Urology organisation with over 24,000 members worldwide.
MBchB, MD, FRCSEd(Urol), FHKAM, FACS
Dr. Chan is the Chair of Asian Urology Residents’ Course. He is the Past President of Hong Kong Urological Association and the Clinical Associate Professor (Honorary) of the Chinese University of Hong Kong and Honorary consultant of Prince of Wales Hospital. His interest in urology includes laparoscopic/robotic urologic surgery. He has more than ten years of experience in robotic surgery. He is actively involving in undergraduates teaching, and residents training in Hong Kong and Asia urologists on minimal invasive and robotic urologic surgery and organizes workshops, lectures and conferences for education and improving the standards of urology practice in HK and other Asia countries.
Dr. Scarpato is an associate professor of urology at Vanderbilt University Medical Center. She completed residency at the University of Connecticut prior to a fellowship in Urologic Oncology at Vanderbilt. She remains on faculty where she serves at the residency program director and the vice chair of education. Her clinical practice and research surround the diagnosis and management of bladder and prostate cancer. She also has interests in surgical simulation, curricular design, global health, and palliative care.
Howard B. Goldman
Howard B. Goldman is a Professor at the Cleveland Clinic Lerner College of Medicine. He has a joint appointment in the departments of urology and obstetrics and gynecology and is the Fellowship director for Female Pelvic Medicine and Reconstructive Surgery. He has directly trained over 35 fellows and residents who are specialized FPMRS practitioners.
His contributions to the literature have been prolific, including author of over 250 articles and book chapters, editor of three textbooks and panel member for a number of standardization, guidelines and best practice statement panels.
He is on the AUA Education committee, serves as online education director for IUGA, was the scientific co-chair for the 2020 ICS annual meeting, was the program co-chair for the 2020 SUFU meeting, was on the program committee for the 2020 International Neurourology Society and is the International Consultation on Incontinence committee chair for surgery for male incontinence.
Dr Goldman has been involved in and led numerous projects related to innovative treatments utilizing stem cells for SUI, neuromodulation, pelvic organ prolapse, utilization of urodynamics, management of complications, robotic surgery and improvements in safety and efficiency in pelvic floor surgery.
Hyung Joon Kim
Dr. Hyung Joon Kim is currently an Associate professor of the Urology Department at Konyang University College of Medicine, Daejeon, South Korea.
He graduated from Yonsei University and completed his urologic residency training at Severance hospital. He did his clinical fellowship in the field of Urological oncology and Robotic surgeries at Samsung Medical Center.
His main areas of interest are Urological Oncology and Endourology, especially in prostate cancer, endoscopic management of urinary stones, and minimal invasive surgeries (MIS), including Robotics. He serves as a board member of the Korean Society of Endourology and Robotics (KSER), Korean Urological Oncology Society (KUOS), and Korean Prostate Society (KPS). He places great importance on sharing knowledge and experience in the field of endourology among international groups. Therefore, he works as the co-organizer of the "Endoluminal & Technology Symposium (ETS)" laid out by the "Collaborate for the Leap of Urological Endoluminal Surgeries (CLUES).”
Jean O’Riordan is a final year urology trainee based in Sydney, Australia. She currently works in Concord Repatriation General Hospital. Her main interest is in female and functional urology. She plans to to do a fellowship in functional and reconstructive urology in UCLH next year. She is grateful for the opportunity to attend this prestigious course.
Dr Jeremy TEOH
Assistant Dean (External Affairs), Faculty of Medicine;
Assistant Professor, S.H. Ho Urology Centre, Department of Surgery,
The Chinese University of Hong Kong,
Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Assistant Professor of the Faculty of medicine, The Chinese University of Hong Kong. He has primary interests in bladder cancer and prostate cancer. For bladder cancer, he is leading a multi-centre randomised controlled trial on transurethral en bloc resection of bladder tumour. He has also developed a global consensus statement to standardise the en bloc resection approach. He is currently studying urinary biomarkers, tumour heterogeneity and molecular classification of bladder cancer. For prostate cancer, he has published extensively on the adverse events related to androgen deprivation therapy. He has helped conduct a clinical trial on the use of the da Vinci Single-Port Surgical System in radical prostatectomy. His team has also introduced focal therapy as a possible treatment option for patients with prostate cancer in Hong Kong.
Dr Teoh has published more than 100 articles in peer-reviewed journals such as European Urology, Journal of Urology and BJU International. He has been a reviewer for more than 30 journals including Cochrane Urology, European Urology, and British Journal of Urology International. He is an editorial board member for a number of prominent journals, and has been serving as a member for several advisory boards for prostate cancer and bladder cancer. He is currently the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong, the Vice-Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine, and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2016. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.
Dr. Joseph Wong graduated in The University of Hong Kong in 2003, and started his urology training in Prince of Wales Hospital in 2005. He acquired the fellowships from the Royal College of Surgeon of Edinburgh and the College of Surgeons of Hong Kong in 2010.
His main clinical interests are kidney cancer and minimal invasive surgery. In 2013, he completed his six months of overseas training in Cleveland Clinic, MD Anderson Cancer Center, and the First Affiliated Hospital of Nanjing Medical University, under the supervision of Dr. Steven Campbell, Dr. Christopher Wood, and Dr. Chang-jun Yin respectively.
His current work focuses on refining the techniques of robotic and laparoscopic partial nephrectomy, including developing retroperitoneal approach, utilization of ICG, and selective arterial clamping. Currently, he is an honorary clinical associate professor of The Chinese University of Hong Kong, and urology consultant in North District Hospital, and also the president of The Hong Kong Society of Endourology.
Dr Wayne Lam is a Clinical Assistant Professor in Urology at The University of Hong Kong. He previously undertook his urological training in London, United Kingdom, including at the prestigious urological units at Guy’s Hospital and St George’s University Hospitals. He completed a fellowship in complex genitourethral reconstructive surgery under Professor Nick Watkin. He underwent dedicated fellowship training in laparoscopic and robotic surgery, precision prostate cancer diagnostics including transperineal prostate biopsy, and endourology including Holmium laser enucleation of the prostate (HoLEP). He was also first to introduce Rezum to Asia in 2020.
Dr Lam leads the tertiary genito-urethral reconstructive service at his institution and has carried out over 200 urethral reconstructive surgeries. His research interests include treatment of benign prostatic hyperplasia (BPH), prostate and penile cancers, reconstructive urology and urolithiasis. He has been an invited speaker at major international meetings, and performed live-surgeries internationally.
Dr Nikhil Vasdev
Consultant Urological and Robotic Surgeon
Associate Medical Director for Cancer Services
Clinical Senior Lecturer
Hertfordshire and Bedfordshire Urological Centre, Lister Hospital, Stevenage, UK
Dr Nikhil Vasdev is a Consultant Urological Surgeon / Associate Medical Director and Co-Director of the RCSEng Robotic Fellowship Programme at the Hertfordshire and Bedfordshire Urological Centre, Lister Hospital, Stevenage, UK. Dr Vasdev specialist interest is Robotic Pelvic Oncology (Prostatectomy and Cystectomy), Intracorporal Urinary Diversion and PDD TURBT. His research group focuses on Biomarker Development, Low pressure Robotic Surgery , Microfluidics, AI and Health Economics. Mr Vasdev has published over 170 peer review articles and is currently in the prestigious “National Clinical Champions Leadership Programme” at the charity Prostate Cancer UK leading the development of patient pathways.
Dr. Ip Man was born in Macau at 1988, activity in local through her teenager, and after that, graduated from Jinan University of China in 2012. Currently work in Centro Hospitalar Conde de São Januário of Macau and serves as a Urologic trainee in the hospital since 2019.
EDUCATIONAL BACKGROUND, TRAINING AND WORK EXPERIENCE
2006/09–2012/07 GUANG ZHOU Jinan University Clinical Medicine
2011/06–2012/06 Medical Trainee: GUANG ZHOU Overseas Chinese Hospital
Kiang Wu Hospital, Macau
2012/08–2012/10 General practitioner: Centro de Formação Juvenil Dom
Bosco, Macau - Resident Medicine Coordinator
2012/10–2014/02 General practitioner: Son Vo Clinic of Macao New Chinese Youth Association
2014/03–2016/10 General practitioner: CHCSJ, Macau - Accident & Emergency department
2016/10 to Recently: CHCSJ, Macau - Urology trainee
2013 Macau Register Medicine License
2015 Register Medicine License of People’s Republic of China
PARTICIPATE in SOCIAL DUTIES and ACTIVITIES
Member of Macau Association of Young Medical Personnel
Name: Chinnawat Wattana
4th year urology resident
Work: Urology division Surgery department of Ramathibodi hospital,
Mahidol University, Bangkok, Thailand
Doctor of Medicine, Mahidol University, Thailand
Jim Dupree, MD, MPH is an Associate Professor of Urology at the University of Michigan in Ann Arbor, Michigan, USA. He is also the Ambulatory Care Clinical Chief for Urology in the University of Michigan Medical Group. He completed his urology residency at Northwestern University and fellowship in Male Reproductive Medicine and Surgery (infertility) at Baylor College of Medicine. He also completed a Health Policy Fellowship with the American College of Surgeons.
Dr. Dupree joined the University of Michigan in 2014 and is a member of the Divisions of Andrology and Health Services Research. Dr. Dupree is an expert in the advanced treatment of male infertility. He also teaches medical students and residents about male infertility, androgens, erectile dysfunction, and health care policy.
Dr. Dupree’s research focuses on reproductive health policy with a special emphasis on access to care, including insurance coverage for infertility. In 2017, Dr. Dupree was awarded the American Urological Association (AUA) James Gallagher Health Policy Scholarship. He served as Chair of the Health Policy Council of the North Central Section of the AUA from 2017-2019. From 2018-2020, he also served on the Board of Directors of the Society for the Study of Male Reproduction (SSMR).